Cargando…

Novel, Precise, Accurate Ion-Pairing Method to Determine the Related Substances of the Fondaparinux Sodium Drug Substance: Low-Molecular-Weight Heparin

Fondaparinux sodium is a synthetic low-molecular-weight heparin (LMWH). This medication is an anticoagulant or a blood thinner, prescribed for the treatment of pulmonary embolism and prevention and treatment of deep vein thrombosis. Its determination in the presence of related impurities was studied...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshpande, Amol A., Madhavan, P., Deshpande, Girish R., Chandel, Ravi Kumar, Yarbagi, Kaviraj M., Joshi, Alok R., Moses Babu, J., Murali Krishna, R., Rao, I. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Austrian Journal of Pharmaceutical Sciences 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839259/ https://www.ncbi.nlm.nih.gov/pubmed/27110496 http://dx.doi.org/10.3797/scipharm.1505-20

Ejemplares similares

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products
por: Vukkum, Pallavi, et al.
Publicado: (2012)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Development of an Ion Chromatography Method for Analysis of Organic Anions (Fumarate, Oxalate, Succinate, and Tartrate) in Single Chromatographic Conditions
por: Kaviraj, Yarbagi, et al.
Publicado: (2015)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

Fondaparinux sodium/heparin: Type II heparin-induced thrombocytopenia and drug cross reactivity: case report
Publicado: (2022)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device
por: Velagic, V., et al.
Publicado: (2014)

Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
por: He, Yumiao, et al.
Publicado: (2018)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
por: Christopher, Amy
Publicado: (2016)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients
por: Benken, Scott T, et al.
Publicado: (2014)

A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux
por: Koul, AN
Publicado: (2015)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases
por: Illuminati, Giulio, et al.
Publicado: (2016)

Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis
por: Kumar, Arun, et al.
Publicado: (2019)

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study
por: Yang, Tianxiang, et al.
Publicado: (2023)

Efficacy and Safety Study of Low-Molecular-Weight Heparin and Fondaparinux Sodium After Hip Arthroplasty: A Retrospective Cohort Study
por: Haibier, Abuduwupuer, et al.
Publicado: (2023)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Azd-1222/fondaparinux-sodium/heparin: Vaccine-induced immune thrombotic thrombocytopenia (VIIT), aggravation of VIIT and lack of efficacy: case report
Publicado: (2021)

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
por: Ghaziri, Dania, et al.
Publicado: (2023)

Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region
por: Moretti, Giaele, et al.
Publicado: (2023)

Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Heparin and Related Substances for Treating Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis
por: Su, Na, et al.
Publicado: (2022)

Elucidation of impact of heavy metal pollution on soil bacterial growth and extracellular polymeric substances flexibility
por: David, Muniswamy, et al.
Publicado: (2016)

Probable fondaparinux-associated bullous hemorrhagic dermatosis
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

ON GROUP SPECIFIC A SUBSTANCES : IV. THE SUBSTANCE FROM HOG STOMACH
por: Landsteiner, K., et al.
Publicado: (1940)

Particle physics: the quest for the substance of substance
por: Okun, Lev Borisovich
Publicado: (1985)

Adverse Drug Reactions Attributed to Fondaparinux and Unfractionated Heparin in Cardiovascular Care Unit: An Observational Prospective Pilot Study in a Tertiary Care Hospital
por: Sharma, Sahithi, et al.
Publicado: (2018)

The Prairie Vole Model of Pair-Bonding and Its Sensitivity to Addictive Substances
por: Potretzke, Sheena, et al.
Publicado: (2019)

A COTS-Based Portable System to Conduct Accurate Substance Concentration Measurements
por: Aznar-Poveda, Juan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ldho5h9jha246jld20qprvojrt